Related Experiment Video

Updated: Apr 8, 2026

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

21.6K

Matrine regulates immune functions to inhibit the proliferation of leukemic cells

Lei Zhang1, Huizhang Zhang2, Zhichao Zhu3

  • 1Department of Advanced Medical Service, Tongji Hospital, Tongji University Shanghai 200065, China.

International Journal of Clinical and Experimental Medicine
|July 2, 2015
PubMed

Insights

Matrine enhances immune cell activity against leukemia by increasing NKG2D ligands on cancer cells and boosting NK and CIK cell cytotoxicity. This natural compound also reduces inflammatory cytokines, inhibiting leukemic cell proliferation.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Leukemia remains a significant health challenge, necessitating novel therapeutic strategies.
  • Understanding the immunomodulatory effects of natural compounds like matrine is crucial for developing new treatments.
  • Matrine, a traditional Chinese medicine alkaloid, has shown potential anti-cancer properties.

Purpose of the Study:

  • To investigate the immunomodulatory roles of matrine.
  • To determine matrine's effect on leukemic cell proliferation.
  • To explore matrine's impact on natural killer (NK) and cytokine-induced killer (CIK) cell activity.

Main Methods:

  • Flow cytometry was used to analyze NKG2D ligands (NKG2DL) on various leukemia cell lines and primary cells, as well as NK cell receptors (NKG2D, CD158a, CD158b).
  • Cytotoxicity assays (CFSE/PI double staining) assessed NK and CIK cell activity against K562 leukemia cells.
  • Pro-inflammatory cytokines and adhesion molecules in cell supernatants were quantified after matrine treatment.

Main Results:

  • Matrine upregulated NKG2DL expression on leukemia cells, enhancing NK and CIK cell-mediated cytotoxicity against K562 cells.
  • Matrine treatment significantly decreased pro-inflammatory cytokines (e.g., IL-6, TNF-α) and adhesion molecules in K562 cell supernatants.
  • Matrine upregulated NKG2D expression and downregulated CD158a/CD158b expression on K562 cells in a dose-dependent manner, while decreasing inflammatory cytokines in NK cell supernatants.

Conclusions:

  • Matrine demonstrates immunomodulatory effects that inhibit leukemic cell proliferation.
  • Matrine enhances anti-leukemic immune responses by modulating NKG2D/NKG2DL interactions and cytokine profiles.
  • These findings suggest matrine as a potential therapeutic agent for leukemia.
Abstract

Keywords:
MatrineNK cellsimmune functionsluekemia cells

More Related Videos

Selective Harvesting of Marginating-pulmonary Leukocytes07:06

Selective Harvesting of Marginating-pulmonary Leukocytes

Published on: March 11, 2016

6.3K
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K